The Global Biotech Handbook offers opportunities in the biotech sector by detailing regulatory landscapes, clinical trial procedures, intellectual property issues, and market structures across 70 ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns. Only five ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

Biotech and pharma facilities face complex environmental compliance challenges involving hazardous waste, emissions, lab safety, and regulatory audits. Learn the risks and best practices.